Rockwell Medical, Inc. (RMTI)

Rockwell Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	12.48	15.66	8.98	10.1	13.28	48.68
Short-Term Investments	5.94	5.94	1.95	11.39	9.16	10
Cash & Short-Term Investments	18.42	21.6	10.94	21.49	22.44	58.68
Cash Growth	55.29%	97.55%	-49.12%	-4.22%	-61.76%	125.30%
Accounts Receivable	8.08	8.29	10.9	6.26	5.91	4.17
Receivables	8.08	8.29	10.9	6.26	5.91	4.17
Inventory	4.16	5.78	5.87	5.81	4.08	3.91
Prepaid Expenses	0.94	1.36	1.06	1.75	2.86	2.71
Total Current Assets	31.61	37.03	28.77	35.31	35.29	69.47
Property, Plant & Equipment	9.6	10.34	11.02	8.61	10.22	5.55
Goodwill	0.92	0.92	0.92	0.92	0.92	0.92
Other Intangible Assets	9.93	10.21	10.76	-	-	-
Other Long-Term Assets	0.56	0.71	0.71	1.8	2.14	1.81
Total Assets	52.63	59.21	52.17	46.64	48.57	77.75
Accounts Payable	1.5	2.87	4.52	4.05	3.74	4.16
Accrued Expenses	2.99	4.86	5.49	7.12	4.29	4.26
Short-Term Debt	0.66	0.27	0.24	0.5	0.44	-
Current Portion of Long-Term Debt	-	-	-	1.63	7.38	-
Current Portion of Leases	2.08	2.17	1.94	2.01	2	1.17
Current Unearned Revenue	2.61	2.51	2.79	1.8	2.32	2.33
Other Current Liabilities	1.1	1.42	1.66	0.59	0.8	0.89
Total Current Liabilities	10.95	14.09	16.64	17.69	20.97	12.79
Long-Term Debt	8.65	8.47	8.29	7.56	13.19	20.95
Long-Term Leases	2.62	2.63	2.96	4.67	5.89	1.82
Long-Term Unearned Revenue	-	1.43	2.98	2.6	5.99	8.02
Other Long-Term Liabilities	-	-	0.01	0.01	0.01	-
Total Liabilities	22.22	26.62	30.88	32.53	46.04	43.58
Common Stock	0	0	0	0	0	0.01
Additional Paid-In Capital	431.03	430.21	418.49	402.7	372.56	371.51
Retained Earnings	-400.69	-397.68	-397.2	-388.76	-370.08	-337.41
Comprehensive Income & Other	0.06	0.05	-0	0.16	0.05	0.06
Shareholders' Equity	30.41	32.59	21.29	14.11	2.54	34.17
Total Liabilities & Equity	52.63	59.21	52.17	46.64	48.57	77.75
Total Debt	14.01	13.54	13.44	16.36	28.9	23.94
Net Cash (Debt)	4.42	8.07	-2.5	5.13	-6.46	34.74
Net Cash Growth	-	-	-	-	-	57.86%
Net Cash Per Share	0.13	0.26	-0.11	0.36	-0.76	5.05
Filing Date Shares Outstanding	34.43	34.06	29.33	12.55	8.54	8.51
Total Common Shares Outstanding	34.43	34.06	29.13	12.16	8.54	8.51
Working Capital	20.66	22.94	12.13	17.62	14.32	56.68
Book Value Per Share	0.88	0.96	0.73	1.16	0.30	4.02
Tangible Book Value	19.56	21.46	9.61	13.19	1.61	33.25
Tangible Book Value Per Share	0.57	0.63	0.33	1.08	0.19	3.91
Machinery	14.69	14.63	13.78	8.57	8.39	7.98
Leasehold Improvements	1.58	1.56	1.42	1.26	1.2	1.2

Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q